Subscribe to our RSS feeds RSS | Login | Register  
 

The CementBloc, Inc

Company: The CementBloc, Inc.

Address Details

641 Sixth Ave
5th Floor
New York, NY 10011
 

Contact Details

Phone: 212-524-6200
Fax: 212-524-6299
 
 
Founded: 2000

Officers: Susan Miller, Ptnr.; Rico Viray, Ptnr.; Ed Cowen, Ptnr.; Andrea Bast, Ptnr.; David Garson, Ptnr.; Daljit Telymonde, EVP, Creative Director; Art Chavez, Ptnr.; Jim Lolis, Ptnr.; Elizabeth Elfenbein, Ptnr.; Jennifer Matthews, Ptnr.;. Healthcare accounts: Actavis Group: FeverAll; Altus: corporate branding; Amylin Pharmaceuticals: corporate branding; Bayer Diabetes Care: Breeze, Contour; Boehringer Ingelheim: Spirvia; Eastern Dental: dental clinics branding; Genzyme Pharmaceuticals: Plerixafor; Mozibil; Medicis: Restylane; Novartis: MS franchise; GenAcqua, GenTeal, GenTeal HA, Visudyne, Vitalux, vaccines franchise; Pfizer: patient advocacy, Lipitor strategic projects; Salix Pharmaceuticals: Giazo, granulated mesalamine; Targanta Therapeutics: Oritavancin; Thomson Healthcare: Physicians' Desk Reference; Tibotec Therapeutics: Prezista, Intellence; UCB Pharma: Cimzia; Sanofi-Aventis/UCB: Xyzal; Vanda Pharmaceuticals: Iloperidone; Vistakon: Novel contact lens system.

Accounts gained (9): Altus Pharmaceuticals: corporate branding; Vanda Pharmaceuticals: Iloperidone; Genzyme Pharmaceuticals: Plerixafor; Mozibil; Amylin Pharmaceuticals: corporate branding; Salix Pharmaceuticals: Giazo, granulated mesalamine; Vistakon: Novel contact lens system; Novartis: multiple sclerosis, vaccine franchise; UCB Consumer: Cimzia.

U.S. billings breakdown by media/source:

Medium20072006
Professional Ads30.0%30.0%
Direct Marketing2.0%2.0%
Sales materials30.0%30.0%
DTC Print5.0%5.0%
Branding, strategy progs. 30.0%30.0%
Conventions/exhibits3.0%3.0%




Offices: 162 5th Avenue, New York, NY 10010

Featured Work
Product: CIMZIA
Client: UCB Inc.
Creative/account team: Copy: Daljit Telymonde, Michelle Holly; Art: Sophie Howland, Tina Lin; Account: Brian Erickson.
Media team: Bob Greene
Why this ad is special: The HCP ad introduces CIMZIA as the first and only FDA-approved PECylated anti-TNF for the treatment of Crohn's disease. The artwork, headline, and key messages are used consistently throughout the CIMZIA campaign and encompass a feeling of "without boundaries."